Bloomberg reports that Pfizer and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine may be needed to neutralize the omicron variant, results that will accelerate booster-shot drives around the world and may lead to use of new strain-specific vaccines.
Active Trading Africa Behavioral Finance Bond Yields Brexit BRICS Buffett Carl Richards China Climate Change Coronavirus COVID-19 DFA Economy Emerging Markets Energy Environment Europe Fama Federal Reserve Frontier Markets GDP Greece IMF Index Funds India Inflation Insight Life Mark Mobius Markets Monetary Policy Oil Passive PIIGS Presidential Elections Retirement Retirement Spending tariffs Trump US Dollar US Economy Volatility Wall Street Journal Young Investor
Chart Room Topics
- Art & Culture
- Articles of Interest
- Behavioral Finance
- Charitable Giving
- China
- Commodities
- COVID-19
- Currency
- DFA
- Downton Abbey Economics
- Emerging Markets
- Environmental
- Europe
- Fama and French
- Global Economy
- Holiday Articles
- Housing Market
- In The News
- Index Funds
- Long-Term Investing
- Low-Cost Investing
- Morningstar
- Opinion
- Philanthropy
- Retirement
- Taxes
- Technology
- Uncategorized
- US Economy
- Valuations
- Young Investor